NDA Number: BN200952
Manufacturer: Hospira, Inc.
Product name: HEXTEND (6% Hydroxyethyl Starch in Lactated Electrolyte Injection)
Indication:

• Treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable. It is not a substitute for blood or plasma.

Product Information

• Package Insert - HEXTEND (6% Hetastarch in Lactated Electrolyte Injection)

Supporting Documents

• October 5, 2021 Approval Letter - HEXTEND (6% Hydroxyethyl Starch in Lactated Electrolyte Injection)
• Supporting Documents older than three years - HEXTEND (6% Hetastarch in Lactated Electrolyte Injection)